Get started
Author

Nicolás Feltes

Observed names: N Feltes, N. Feltes, N. Feltes Benítez, Nicolas Feltes, Nicolas Feltes Benitez, Nicolas Feltes Benítez
ORCID: 0000-0002-2607-9904
Observed ORCID: 0000-0002-2607-9904
OpenAlex ID: A5077281165
PSA bounce: understanding temporal fluctuations in prostate cancer after external radiotherapy
2024 · Nicolas Feltes Benitez, Joan Lozano, et al. · Clinical & Translational Oncology · 3
Use of social media in radiation oncology: multicenter data from the GOCO Group
2024 · Marta Bonet, Enar Recalde, et al. · Reports of Practical Oncology & Radiotherapy · 3
PDF
Nadir prostate-specific antigen after salvage cryotherapy as a potential prognostic factor for oncologic outcomes
2024 · E. Carbonell, C. Mercader, et al. · World Journal of Urology · 3
Preventing Skin Toxicity in Breast Cancer Patients Undergoing Radiotherapy With an Emulsion Containing Hyaluronic Acid, Chondroitin Sulfate, Aloe Vera, Carrot Oil, Vitamin F and Vitamin E
2011 · J. Pardo, M. Murcia, et al. · Radiotherapy and Oncology · 3
Prognostic Factors Associated with Biochemical Relapse After Radiotherapy in Localized Prostate Cancer: A Retrospective Cohort Study
2025 · Nicolas Feltes Benitez, Felipe Couñago, et al. · Biomedicines · 2
PDF
Management of high-risk and post-operative non-metastatic prostate cancer in Catalonia: an expert Delphi consensus
2022 · Marta Bonet, David González, et al. · Clinical & Translational Oncology · 2
Anterior left ventricular territory: True oar in left breast radiotherapy
2013 · A. Folgar-torres, A. Alvarado-astudillo, et al. · Reports of Practical Oncology & Radiotherapy · 2
The Role of SBRT in Oligometastatic Prostate Cancer: Where We Are and Where We Are Heading
2026 · Macarena Teja, Miguel Angel Berenguer Frances, et al. · Life · 1
PDF
CT-Based Quantification of Prostate Volume Change After LHRH-Agonist Androgen Deprivation: A Prospective, Three-Reader Study for Radiotherapy Planning
2025 · Nicolas Feltes Benitez, Manuel Galdeano-Rubio, et al. · Life · 1
PDF
Po-0658 When to Start Radiotherapy in Glioblastoma Multiforme(gbm) Patients. Is It Sooner, the Best?
2012 · A. Alvarado-Astudillo, N. Feltes, et al. · Radiotherapy and Oncology · 1
Response to Palliative Radiotherapy (PRT) in Patients (PTS) with Painful Bone Metastases depending on the site of Metastases and the Primary Tumor
2011 · J. Pardo, M. Murcia, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
Assessing the Efficiency of Glutamine Treatment for Preventing Acute Oesophagitis in Lung Cancer Patients Treated With Radiochemotherapy
2011 · J. Luna, T. Iglesias, et al. · Radiotherapy and Oncology · 1
Preventing Acute Rectitis and Cystitis With Glutamine in Prostate Cancer Patients Treated With Radiotherapy
2011 · J. Olivera, A. Chavez, et al. · Radiotherapy and Oncology · 1
2078 Prognostic Factors for Recurrence and Survival in Bladder-Preserving Therapy for Muscle-Invasive Bladder Cancer
2026 · Nicolas Feltes Benitez, Felipe Couñago, et al. · Radiotherapy and Oncology
Prognostic factors and oncological outcomes after trimodality bladder-preserving therapy for muscle-invasive bladder cancer: A multicenter real-world study
2026 · N. Feltes Benítez, F. Couñago, et al. · Actas Urológicas Españolas (English Edition)
Factores pronósticos y resultados oncológicos tras terapia trimodal con preservación vesical en el cáncer de vejiga músculo invasivo: estudio multicéntrico en práctica clínica real
2026 · N. Feltes Benítez, F. Couñago, et al. · Actas Urológicas Españolas
Interim analysis of the PROVIDENCE study: An AI-based model for predicting metastatic recurrence in localized prostate cancer patients using quantitative imaging biomarkers and clinical data
2025 · A.J. Conde Moreno, A. Torregrosa Andrés, et al. · European Urology Open Science
Biochemical response to enzalutamide in PET-PSMA-detected metastatic hormone sensitive prostate cancer (mHSPC): A real-world multicenter study based on ultralow PSA criteria
2025 · J. Azcona Martín, S. García Barreras, et al. · European Urology Open Science
Prostate Volume Reduction in Prostate Cancer: Predictive Factors after LHRHa Therapy
2025 · N. Feltes, S. Paredes, et al. · International Journal of Radiation Oncology*Biology*Physics
Prognostic Factors for Recurrence and Survival in Bladder-Preserving Therapy for Muscle-Invasive Bladder Cancer
2025 · N. Feltes, S. Paredes, et al. · International Journal of Radiation Oncology*Biology*Physics
PDF
Fecal incontinence after moderately hypofractionated volumetric modulated arc therapy for prostate cancer: incidence and impact on quality of life
2025 · Joan Lozano, Nicolas Feltes, et al. · Clinical & Translational Oncology
P067 An interim analysis of the multi center retrospective study PROVIDENCE: Artificial intelligence-based models for estimating the risk of biochemical recurrence with clinical data
2024 · A.J. Conde-Moreno, A. Torregrosa Andrés, et al. · European Urology Open Science
894: Use of Social Media in Radiation Oncology: Multicenter Data from the GOCO Group
2024 · Marta Bonet, Enar Recalde, et al. · Radiotherapy and Oncology
208: Fecal incontinence after moderately hypofractionated VMAT fof localised prostate cancer
2024 · Joan Lozano, Esther Jovell, et al. · Radiotherapy and Oncology
Fecal incontinence after moderately hypofractionated volumetric modulated arc therapy: incidence and impact on quality of life in a real-world practice
2023 · J. Lozano, E Jovell, et al. · European Urology Open Science
Works count: 40
Citation count: 24
H-index: 3
I10-index:
Year
Topic
Type